MondegarAI
Newtyn Management, LLC

Q2 2025 · 13F-HR

Newtyn Management, LLCholdings as filed

Filed 2025-08-14 · accession 0001641172-25-024002

$660.0M
Reported value
34
Positions
2025-06-30
Period end
View analyzed profile →PRO

The Brief · Newtyn Management, LLC · Q2 2025

AI · grounded in 13F

Newtyn Management, LLC established a new position in CNNE valued at $92.3M. The fund also initiated stakes in TBPH for $54.6M and QDEL for $49.2M. Additional new positions include AIV at $44.9M and BV at $41.4M. The fund ended the period with 34 positions and total AUM of $660M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
13765N107CNNECANNAE HLDGS INC$92.3M14.0%4,425,000CommonSOLE
G8807B106TBPHTHERAVANCE BIOPHARMA INC$54.6M8.27%4,950,000CommonSOLE
219798105QDELQUIDELORTHO CORP$49.2M7.45%1,705,668CommonSOLE
03748R747AIVAPARTMENT INVT & MGMT CO$44.9M6.80%5,190,472CommonSOLE
10948C107BVBRIGHTVIEW HLDGS INC$41.4M6.28%2,487,572CommonSOLE
G4766E116INDVINDIVIOR PLC$38.4M5.82%2,607,018CommonSOLE
44891N208IACIAC INC$37.3M5.66%1,000,000CommonSOLE
19239V302CCOICOGENT COMMUNICATIONS HLDGS$30.1M4.57%625,000CommonSOLE
698884103PARPAR TECHNOLOGY CORP$29.5M4.47%425,000CommonSOLE
55939A107MAGNMAGNERA CORP$27.4M4.16%2,271,500CommonSOLE
20451N101CMPCOMPASS MINERALS INTL INC$25.7M3.89%1,277,183CommonSOLE
601137102MRPMILLROSE PPTYS INC$23.0M3.49%807,135CommonSOLE
178587101CIOCITY OFFICE REIT INC$21.0M3.19%3,938,000CommonSOLE
84790A105SPBSPECTRUM BRANDS HLDGS INC NE$13.2M2.01%249,937CommonSOLE
82981J851SITCSITE CTRS CORP$12.4M1.89%1,100,000CommonSOLE
35471R106FSPFRANKLIN STR PPTYS CORP$11.7M1.78%7,150,000CommonSOLE
315948109FBTCFIDELITY WISE ORIGIN BITCOIN$11.3M1.71%120,200CommonSOLE
25862V105DVDOUBLEVERIFY HLDGS INC$10.5M1.59%700,000CommonSOLE
384747101GRALGRAIL INC$10.3M1.56%200,000CommonSOLE
76134H101RHLDRESOLUTE HLDGS MGMT INC$8.8M1.33%275,000CommonSOLE
415864107NVRIENVIRI CORP$8.7M1.32%1,001,018CommonSOLE
65342T106NODKNI HLDGS INC$8.5M1.29%670,000CommonSOLE
68243Q106FLWS1 800 FLOWERS COM INC$7.9M1.20%1,609,555CommonSOLE
78667J108SG7SAGE THERAPEUTICS INC$6.4M0.97%700,000CommonSOLE
001744101AMNAMN HEALTHCARE SVCS INC$5.9M0.90%287,038CommonSOLE
46565G1045E7ITEOS THERAPEUTICS INC$5.7M0.86%567,416CommonSOLE
77313F106RCKTROCKET PHARMACEUTICALS INC$4.9M0.74%2,000,000CommonSOLE
606710200MITKMITEK SYS INC$4.8M0.73%484,954CommonSOLE
492327101KROSKEROS THERAPEUTICS INC$3.3M0.50%246,857CommonSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$2.7M0.41%480,000CommonSOLE
Y95308105WVEWAVE LIFE SCIENCES LTD$2.6M0.39%400,000CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$2.1M0.32%580,000CommonSOLE
282559103ETNBGBP89BIO INC$2.0M0.30%200,000CommonSOLE
G63365103MURAMURAL ONCOLOGY PUB LTD CO$1.4M0.21%570,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.